AstraZeneca forecasts steady growth in 2026 on strong cancer drug demand, shares rise February 10, 2026 by wealthalpha Other news AstraZeneca forecasts steady growth in 2026 on strong cancer drug demand, shares rise Source link Previous News European stocks mixed with corporate earnings in spotlight; BP suspends buybacks Next News 7000% return in 3 years: Elitecon International share price hits 5% upper circuit for third straight day wealthalpha
Leave A Comment